The effect of vitamin D supplementation on serum lipids in postmenopausal women with diabetes: A randomized controlled trial

Clinical Nutrition

Volumn 34, Issue 5, 2015, Pages 799-804

  Muñoz Aguirre, Paloma ^a   Flores, Mario ^a   Macias, Nayeli ^a   Quezada, Amado D ^a   Denova Gutiérrez, Edgar ^b,c   Salmerón, Jorge ^a,c  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE HIDALGO   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Postmenopausal women; Serum lipids; Vitamin D supplementation

Indexed keywords

C REACTIVE PROTEIN; CALCIFEDIOL; CHOLESTEROL; COLECALCIFEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; PLACEBO; TRIACYLGLYCEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VITAMIN D;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FACTORIAL DESIGN; FEMALE; FOLLOW UP; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTENTION TO TREAT ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL ASSESSMENT; OBESITY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; BLOOD; BODY MASS; BODY WEIGHT; DIETARY SUPPLEMENT; DOSE RESPONSE; METABOLISM; MIDDLE AGED;

AGED; BODY MASS INDEX; BODY WEIGHT; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NUTRITION ASSESSMENT; POSTMENOPAUSE; TRIGLYCERIDES; VITAMIN D;

EID: 84939269114     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.10.002     Document Type: Article

References (30)

1. Global status report on noncommunicable disaeses 2010 2011, World Health Organization, Geneva.
2. Baker L., Meldrum K.K., Wang M., Sankula R., Vanam R., Raiesdana A., et al. The role of estrogen in cardiovascular disease. J Surg Res 2003, 115(2):325-344.
3. Holick M. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
4. Parker J., Hashmi O., Dutton D., Mavrodaris A., Stranges S., Kandala N.B., et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010, 65:225-236.
5. Michos E.D., Blumenthal R.S. Vitamin D supplementation and cardiovascular disease risk. Circ 2007, 115:827-828.
6. Boon N., Hul G.B., Stegen J.H., Sluijsmans W.E., Valle C., Langin D., et al. An intervention study of the effects of calcium intake on faecal fat excretion, energy metabolism and adipose tissue mRNA expression of lipid metabolism related proteins. Int J Obes 2007, 31:1704-1712.
7. Jorde R., Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 2011, 50(4):303-312.
8. Maki K.C., Rubin M.R., Wong L.G., McManus J.F., Jensen C.D., Marshall J.W., et al. Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. J Clin Lipidol 2009, 3:289-296.
9. Flores M. A role of vitamin D in low-intensity chronic inflammation and insulin resistance in type 2 diabetes mellitus?. Nutr Res Rev 2005, 18:175-182.
10. Wang C. Role of Vitamin D in cardiometabolic diseases. J Diabetes Res 2013, 2013:243934. 10.1155/2013/243934.
11. Denova-Gutiérrez E., Castañón S., Talavera J.O., Flores M., Macías N., Rodríguez-Ramírez S., et al. Dietary patterns are associated with different indexes of adiposity and obesity in an urban Mexican population. J Nutr 2011, 141(5):921-927.
12. Turpeinen U., Hohenthal U., Stenman U.H. Determination of 25-hydroxyvitamin D in serum by HPLC and immunoassay. Clin Chem 2003, 49:1521-1524.
13. Hernández-Ávila M., Romieu I., Parra S., Hernández-Avila J., Madrigal H., Willett W. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Pública Mex 1998, 40:133-140.
14. Hernández-Ávila M., Resoles M., Parra S. Sistema de evaluación de hábitos nutricionales y consumo de nutrimentos (SNUT) 2000, INSP, Mexico.
15. Martínez G.M.A., López F.C., Varo J.J., Sánchez V.A., Martínez J.A. Validation of the Spanish version of the physical activity questionnaire used in the nurses' health study and the health professionals' follow-up study. Public Health Nutr 2005, 8:920-927.
16. Bausell R.B., Li Y.F. Power analysis for experimental research: a practical guide for the biological, medical and social sciences 2002, Cambridge University Press, Cambridge.
17. Guo S., Fraser M.W. Propensity score analysis 2010, Sage Publications, Inc.
18. Wand M.P., Jones M.C. Kernel smoothing 1995, Chapman and Hall/CRC, London.
19. Jorde R., Figenschau Y., Hutchinson M., Emaus N., Grimnes G. High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. Eur J Clin Nutr 2010, 64(12):1457-1464.
20. Bolland M.J., Bacon C.J., Horne A.M., Mason B.H., Ames R.W., Wang T.K., et al. Vitamin D insufficiency and health outcomes over 5 y in older women. Am J Clin Nutr 2010, 91:82-89.
21. Karhapää P., Pihlajamäki J., Pörsti I., Kastarinen M., Mustonen J., Niemelä O., et al. Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias. J Intern Med 2010, 268(6):604-610.
22. Wang H., Xia N., Yang Y., Peng D.Q. Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis 2012, 11:42.
23. Jorde R., Sneve M., Torjesen P., Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2010, 267(5):462-472.
24. Zittermann A., Frisch S., Berthold H.K., Götting C., Kuhn J., Kleesiek K., et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009, 89(5):1321-1327.
25. Nagpal J., Pande J.N., Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 2009, 26(1):19-27.
26. Reid I.R. Effects of calcium suplementation on circulating lipids: potential pharmacoeconomic implications. Drugs Aging 2004, 21:7-17.
27. Zemel M.B., Shi H., Greer B., Dirienzo D., Zemel P.C. Regulation of adiposity by dietary calcium. FASEB J 2000, 14:1132-1138.
28. Heikkinen A.M., Tuppurainen M.T., Niskanen L., Komulainen M., Penttilä I., Saarikoski S. Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol 1997, 137(5):495-502.
29. Sai A.J., Gallagher J.C., Fang X. Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes. Menopause 2011, 18(10):1101-1112.
30. Heaney R.P., Vieth R., Hollis B.W. Vitamin D efficacy and safety. Arch Intern Med 2011, 171(3):266.